【研究成果】111年度 中心研究人員成果彙整

年份篇數IF>5IF>10TOP10%TOP25%
202331221
202238103512
202161  1

Publications (2021-2023 Jan)

  1. Liao SF, Su CY, Su MH, Chen CY, Chen CY, Lin YF, Pan YJ, Hsiao PC, Chen PC, Huang YT, Wu CS, Wang SH. Associations of polygenic risks, depression, and obesity-related traits in Taiwan Biobank. J Affect Disord. 2023;(320):397-403. (IF 6.533, TOP15%)
  2. Yen FS, Wei JCC, Yip HT, Hsu CC, Hwu CM. Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes. Journal of Medical Virology. 2023 Jan;95(1):Article number e28278. (IF 20.693, TOP5%)
  3. Yen FS, Hou MC, Pan CW, Liu JS, Hsu CC, Hwu CM. The Risk of Severe Hypoglycemia and Mortality in Patients With Type 2 Diabetes and Discharged With Acute Liver Injury. Diabetes Care. 2023;46(1):20-7. (IF 17.155, TOP5%)
  4. Yen FS, Wei JC, Yu TS, Hsu CY, Hsu CC, Hwu CM. Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study. Int J Environ Res Public Health. 2022;19(22). (IF 2.849, TOP25%)
  5. Yen FS, Wei JC, Yip HT, Hwu CM, Hsu CC. Diabetes, Hypertension, and the Risk of Dementia. J Alzheimers Dis. 2022;89(1):323-33. (IF 4.160)
  6. Yen FS, Wei JC, Shih YH, Pan WL, Hsu CC, Hwu CM. Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes. J Pers Med. 2022;12(5). (IF 3.508)
  7. Yen FS, Wei JC, Shih YH, Hsu CY, Hsu CC, Hwu CM. Metformin Use before Influenza Vaccination May Lower the Risks of Influenza and Related Complications. Vaccines (Basel). 2022;10(10). (IF 4.961)
  8. Yen FS, Wei JC, Shih YH, Hsu CC, Hwu CM. Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes. Sci Rep. 2022;12(1):3270. (IF 4.997, TOP25%)
  9. Yen FS, Wei JC, Liu JS, Hsu CC, Hwu CM. Clinical course of adolescents with type 2 diabetes mellitus: A nationwide cohort study in Taiwan. J Diabetes Investig. 2022;13(11):1905-13. (IF 3.681)
  10. Yen FS, Wei JC, Chiu LT, Hsu CC, Hwu CM. Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease. Front Pharmacol. 2022;13:919881. (IF 5.988, TOP20%)
  11. Yen FS, Hsu CC, Hu KC, Hung YT, Hsu CY, Wei JC, et al. Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes. Int J Environ Res Public Health. 2022;19(17). (IF 4.614, TOP25%)
  12. Yen FS, Cheng-Chung Wei J, Hung YT, Hsu CC, Hwu CM. Long-term outcomes of the pay-for-performance program for patients with young-onset (20-40 years of age) type 2 diabetes. Diabetes Res Clin Pract. 2022;193:110136. (IF 8.180, TOP15%)
  13. Yang JJ, Yen HK, Li CY, Chen HJ, Liou HH, Fu SH, Wang CY. Ten existing osteoporosis prediction tools for the successful application of National Health Insurance-reimbursed anti-osteoporosis medications in long-term care residents in Taiwan. J Formos Med Assoc. 2022. (IF 3.871, TOP20%)
  14. Wu CY, Liu JS, Chen CH, Huang CT, Yu TM, Chuang YW, Huang ST, Hsu CC, Wu MJ. Early Comprehensive Kidney Care in Dialysis-Requiring Acute Kidney Injury Survivors: A Populational Study. Front Med (Lausanne). 2022;9:847462. (IF 5.058)
  15. Wu CS, Liao SC, Huang WL. Use of machine learning to diagnose somatic symptom disorder: Are the biomarkers beneficial for the diagnosis? World J Biol Psychiatry. 2022:1-11. (IF 3.418)
  16. Wang SH, Wu CS, Hsu LY, Lin MC, Chen PC, Thompson WK, et al. Paternal age and 13 psychiatric disorders in the offspring: a population-based cohort study of 7 million children in Taiwan. Mol Psychiatry. 2022;27(12):5244-54. (IF 13.437, TOP5%)
  17. Wang SH, Su MH, Chen CY, Lin YF, Feng YA, Hsiao PC, Pan YJ, Wu CS. Causality of abdominal obesity on cognition: a trans-ethnic Mendelian randomization study. Int J Obes (Lond). 2022;46(8):1487-92. (IF 5.551, TOP15%)
  18. Wang JS, Wu YL, Ou HY, Yang YS, Hsu CC, Hwu CM. Trends in all-cause mortality and major causes of death between 2007 and 2018 among patients with diabetes in Taiwan. Front Endocrinol (Lausanne). 2022;13:984137. (IF 6.055, TOP25%)
  19. Wang HH, Chang CM, Chang SS, Yang AC, Liu YH, Liao SC, Wu CS. Ten-year trends in depression care in Taiwan. J Formos Med Assoc. 2022;121(10):2001-11. (IF 3.871, TOP20%)
  20. Wang CK, Wang FD, Lee YQ, Chen PT, Wang BH, Su CH, Wu CS, et al. Principle-Based Approach for the De-Identification of Code-Mixed Electronic Health Records. Ieee Access. 2022;10:22875-85. (IF 3.476)
  21. Tu CY, Yen TH, Chang CM, Chen HY, Yen YC, Guo MC, Lu TH, Wu CS, et al. Characteristics and psychopathology of 1,086 patients who self-poisoned using pesticides in Taiwan (2012-2019): A comparison across pesticide groups. J Affect Disord. 2022;300:17-26. (IF 6.533, TOP15%)
  22. Lin YH, Wu CS, Liu CC, Kuo PH, Chan HY, Chen WJ. Comparative Effectiveness of Antipsychotics in Preventing Readmission for First-Admission Schizophrenia Patients in National Cohorts From 2001 to 2017 in Taiwan. Schizophr Bull. 2022;48(4):785-94. (IF 7.348, TOP10%)
  23. Liao WT, Huang JY, Lee MT, Yang YC, Wu CC. Higher risk of type 2 diabetes in young women with polycystic ovary syndrome: A 10-year retrospective cohort study. World J Diabetes. 2022;13(3):240-50. (IF 4.560)
  24. Lai RH, Hsu CC, Yu BH, Lo YR, Hsu YY, Chen MH, et al. Vitamin D supplementation worsens Alzheimer’s progression: Animal model and human cohort studies. Aging Cell. 2022;21(8):e13670. (IF 11.0, TOP5%)
  25. Kuo FL, Yen CM, Chen HJ, Liao ZY, Lee Y. Trajectories of mobility difficulty and falls in community-dwelling adults aged 50 + in Taiwan from 2003 to 2015. BMC Geriatr. 2022;22(1):902. (IF 4.070)
  26. Ku MC, Tsai YH, Cheng PC, Yang TI, Ho HW, Liao MF, Tseng YT, Lee MT, Chen YN. After Total Knee Arthroplasty, Monitored Active Ankle Pumping Improves Lower Leg Circulation More Than Unmonitored Pumping: A Pilot Study. Appl Sci-Basel. 2022;12(18). (IF 2.838)
  27. Kao YH, Hsu CC, Yang YH. A Nationwide Survey of Dementia Prevalence in Long-Term Care Facilities in Taiwan. J Clin Med. 2022;11(6). (IF 4.964)
  28. Hung YA, Liao SC, Chang CM, Chang SS, Yang AC, Chien YL, Wu CS, Gau SSF. Population-attributable risk of psychiatric disorders for suicide among adolescents and young adults in Taiwan. Psychol Med. 2022:1-10. (IF 10.592, TOP5%)
  29. Huang WL, Chiang CL, Wu CS, Liao SC, Chien TH, Tseng CH, et al. Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan. J Affect Disord. 2022;319:40-7. (IF 6.533, TOP15%)
  30. Chou PH, Wang SC, Wu CS, Horikoshi M, Ito M. A machine-learning model to predict suicide risk in Japan based on national survey data. Front Psychiatry. 2022;13:918667. (IF 5.435)
  31. Chien YL, Wu CS, Chang YC, Cheong ML, Yao TC, Tsai HJ. Associations between parental psychiatric disorders and autism spectrum disorder in the offspring. Autism Res. 2022;15(12):2409-19. (IF 4.633, TOP15%)
  32. Chien CF, Huang LC, Chang YP, Lin CF, Hsu CC, Yang YH. What factors contribute to the need for physical restraint in institutionalized residents in Taiwan? PLoS One. 2022;17(11):e0276058. (IF 3.752)
  33. Chen HC, Wang CY, Chen HH, Liou HH. Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson’s disease when considering the coexisting effects of diabetes mellitus. PLoS One. 2022;17(8):e0269006. (IF 3.752)
  34. Chang TY, Liao SC, Chang CM, Wu CS, Huang WL, Hwang JJ, Hsu CC. Barriers to depression care among middle-aged and older adults in Taiwan’s universal healthcare system. Lancet Reg Health West Pac. 2022;26:100501. (IF 8.559, TOP10%)
  35. Chang CS, Huang CW, Chou HH, Tu HT, Lee MT, Huang CF. A Pathophysiological Approach to Reduce Peritumoral Edema with Gamma Knife Radiosurgery for Large Incidental Meningiomas. Life (Basel). 2022;12(11). (IF 3.253)
  36. Yen CM. Learning to change: Transformative outcomes of programmes and activities for family caregivers of people with dementia in Taiwan. Aust J Adult Learn. 2021;61(2):241-66. (IF 1.075)
  37. Wu CS, Yang AC, Chang SS, Chang CM, Liu YH, Liao SC, et al. Validation of Machine Learning-Based Individualized Treatment for Depressive Disorder Using Target Trial Emulation. J Pers Med. 2021;11(12). (IF 3.508)
  38. Wu CS, Hsu LY, Pan YJ, Wang SH. Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus. J Clin Endocr Metab. 2021;106(12):E5136-E46. (IF 6.134, TOP25%)
  39. Chen HC, Chou MC, Lee MT, Lee CY, Yang CN, Liu CH, et al. The Diagnostic Value of Pulsar Perimetry, Optical Coherence Tomography, and Optical Coherence Tomography Angiography in Pre-Perimetric and Perimetric Glaucoma. J Clin Med. 2021;10(24). (IF 4.964)
  40. Chang HL, Chao SC, Lee MT, Lin HY. Micropulse Transscleral Cyclophotocoagulation as Primary Surgical Treatment for Primary Open Angle Glaucoma in Taiwan during the COVID-19 Pandemic. Healthcare-Basel. 2021;9(11). (IF 3.160)
  41. Hsu CC. The challenges and strategies for coping with super-aged society in Taiwan. 2022;41(2):109-11.
  42. 傅紹懷, 陳弘哲, 嚴竑寬, 吳至行, 陳合旻, 李中一, et al. 骨質疏鬆篩檢問卷篩檢長照住民骨質疏鬆之效度。中華民國骨鬆醫學會2022年7月會訊。2022;13(3):22-6.
  43. 傅紹懷, 陳弘哲, 李銘宗, 陳合旻, 吳至行, 李中一, et al. 長照住民骨密度檢查之骨質疏鬆盛行率. 中華民國骨鬆醫學會2022年7月會訊。 2022;13(3):14-7.
  44. 傅紹懷, 李銘宗, 楊榮森, 李中一, 王貞予. 長照住民之骨質疏鬆治療效果. 中華民國骨鬆醫學會2022年7月會訊。2022;13(3):18-21.
  45. 傅紹懷, 李銘宗, 楊榮森, 李中一, 王貞予. 長照住民鈣片、維他命D、及骨質疏鬆治療狀況. 中華民國骨鬆醫學會2022年7月會訊。2022;13(3):10-3.
  46. 傅紹懷, 李銘宗, 楊榮森, 李中一, 王貞予. 長照住民之骨折風險—以骨折風險評估工具FRAX評估. 中華民國骨鬆醫學會2022年7月會訊。2022;13(3):6-9.
  47. 傅紹齊, 傅紹懷, 王貞予. 使用藥物治療長照中心住民骨質疏鬆所遇到的困難. 中華民國骨鬆醫學會2022年7月會訊。2022;13(3):27-30.